Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Insight Molecular Diagnostics (IMDX) Shares Issued: 2020-2025

Historic Shares Issued for Insight Molecular Diagnostics (IMDX) over the last 1 years, with Mar 2025 value amounting to $29.1 million.

  • Insight Molecular Diagnostics' Shares Issued was N/A to $29.1 million in Q1 2025 from the same period last year, while for Mar 2025 it was $60.2 million, marking a year-over-year change of. This contributed to the annual value of $26.0 million for FY2024, which is 87.84% up from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Shares Issued of $29.1 million as of Q1 2025, which was up 185.58% from $10.2 million recorded in Q4 2024.
  • Insight Molecular Diagnostics' Shares Issued's 5-year high stood at $65.3 million during Q1 2021, with a 5-year trough of $1,000 in Q4 2021.
  • Moreover, its 2-year median value for Shares Issued was $15.8 million (2024), whereas its average is $18.4 million.
  • Per our database at Business Quant, Insight Molecular Diagnostics' Shares Issued spiked by 759.05% in 2021 and then plummeted by 99.95% in 2022.
  • Quarterly analysis of 4 years shows Insight Molecular Diagnostics' Shares Issued stood at $1,000 in 2021, then plummeted by 99.95% to $5.0 million in 2022, then reached $10.2 million in 2024, then reached $29.1 million in 2025.
  • Its last three reported values are $29.1 million in Q1 2025, $10.2 million for Q4 2024, and $15.8 million during Q2 2024.